Junpei Yamaguchi1,2, Yuji Kaneoka3, Atsuyuki Maeda3, Yuichi Takayama3, Shunsuke Onoe3, Masatoshi Isogai3. 1. Division of Digestive Surgery, Ogaki Municipal Hospital, Ogaki, Gifu, Japan. jumpei@med.nagoya-u.ac.jp. 2. Surgical Oncology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan. jumpei@med.nagoya-u.ac.jp. 3. Division of Digestive Surgery, Ogaki Municipal Hospital, Ogaki, Gifu, Japan.
Abstract
PURPOSE: We aimed to define the benefit of extended radical surgery for incidental gallbladder carcinoma (IGC), the most appropriate treatment for which remains controversial. METHODS: We analyzed retrospectively the management strategies and prognoses of 28 patients with IGC treated in our hospital. RESULTS: After initial cholecystectomy, 10, 5, and 13 of the 28 patients were found to have T1a (m), T1b (mp), and T2 (ss) disease, respectively. The patients with T1a disease (T1a group) had a good prognosis; however, 9 of the 18 patients with T1b or T2 disease required additional S4a + 5 segmentectomy of the liver and bile duct resection (extended radical surgery; re-resected group), while 9 did not undergo additional treatment because of their poor general condition (no-treatment group). The re-resected group had a favorable prognosis, with an 88.9% 5-year disease-specific survival (DSS) rate, which was significantly better than that of the non-treatment group (30.5%, p = 0.015) and comparable to that of the T1a group (90.0%, p = 0.97). Examination of the re-resected specimens revealed residual disease in 44% (4/9). CONCLUSION: Additional extended radical surgery improved the prognosis of patients with IGC, suggesting that there is curative potential in most cases.
PURPOSE: We aimed to define the benefit of extended radical surgery for incidental gallbladder carcinoma (IGC), the most appropriate treatment for which remains controversial. METHODS: We analyzed retrospectively the management strategies and prognoses of 28 patients with IGC treated in our hospital. RESULTS: After initial cholecystectomy, 10, 5, and 13 of the 28 patients were found to have T1a (m), T1b (mp), and T2 (ss) disease, respectively. The patients with T1a disease (T1a group) had a good prognosis; however, 9 of the 18 patients with T1b or T2 disease required additional S4a + 5 segmentectomy of the liver and bile duct resection (extended radical surgery; re-resected group), while 9 did not undergo additional treatment because of their poor general condition (no-treatment group). The re-resected group had a favorable prognosis, with an 88.9% 5-year disease-specific survival (DSS) rate, which was significantly better than that of the non-treatment group (30.5%, p = 0.015) and comparable to that of the T1a group (90.0%, p = 0.97). Examination of the re-resected specimens revealed residual disease in 44% (4/9). CONCLUSION: Additional extended radical surgery improved the prognosis of patients with IGC, suggesting that there is curative potential in most cases.
Authors: Jean M Butte; Kenichi Matsuo; Mithat Gönen; Michael I D'Angelica; Enrique Waugh; Peter J Allen; Yuman Fong; Ronald P DeMatteo; Leslie Blumgart; Itaru Endo; Hernán De La Fuente; William R Jarnagin Journal: J Am Coll Surg Date: 2010-11-12 Impact factor: 6.113
Authors: Hiromichi Ito; Kaori Ito; Michael D'Angelica; Mithat Gonen; David Klimstra; Peter Allen; Ronald P DeMatteo; Yuman Fong; Leslie H Blumgart; William R Jarnagin Journal: Ann Surg Date: 2011-08 Impact factor: 12.969
Authors: Eric H Jensen; Anasooya Abraham; Elizabeth B Habermann; Waddah B Al-Refaie; Selwyn M Vickers; Beth A Virnig; Todd M Tuttle Journal: J Gastrointest Surg Date: 2008-12-13 Impact factor: 3.452
Authors: D Fuks; J-M Regimbeau; P Pessaux; P Bachellier; A Raventos; G Mantion; J-F Gigot; L Chiche; G Pascal; D Azoulay; A Laurent; C Letoublon; E Boleslawski; M Rivoire; J-Y Mabrut; M Adham; Y-P Le Treut; J-R Delpero; F Navarro; A Ayav; K Boudjema; G Nuzzo; M Scotte; O Farges Journal: J Visc Surg Date: 2013-05-09 Impact factor: 2.043